nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—HTR2C—bipolar disorder	0.179	0.235	CbGaD
Nortriptyline—HTR1A—bipolar disorder	0.174	0.228	CbGaD
Nortriptyline—SLC6A4—bipolar disorder	0.149	0.194	CbGaD
Nortriptyline—DRD2—bipolar disorder	0.148	0.193	CbGaD
Nortriptyline—HTR2A—bipolar disorder	0.114	0.149	CbGaD
Nortriptyline—SLC6A2—locus ceruleus—bipolar disorder	0.00633	0.0815	CbGeAlD
Nortriptyline—ORM1—saliva—bipolar disorder	0.00438	0.0564	CbGeAlD
Nortriptyline—HTR2A—locus ceruleus—bipolar disorder	0.0038	0.049	CbGeAlD
Nortriptyline—HTR2C—telencephalic ventricle—bipolar disorder	0.00359	0.0463	CbGeAlD
Nortriptyline—SLC6A2—autonomic nervous system—bipolar disorder	0.00336	0.0433	CbGeAlD
Nortriptyline—HTR1A—telencephalic ventricle—bipolar disorder	0.00303	0.039	CbGeAlD
Nortriptyline—DRD2—telencephalic ventricle—bipolar disorder	0.00273	0.0352	CbGeAlD
Nortriptyline—CYP2C19—urine—bipolar disorder	0.00258	0.0332	CbGeAlD
Nortriptyline—CYP1A2—urine—bipolar disorder	0.00211	0.0271	CbGeAlD
Nortriptyline—HTR2A—autonomic nervous system—bipolar disorder	0.00202	0.026	CbGeAlD
Nortriptyline—CYP2C9—urine—bipolar disorder	0.002	0.0258	CbGeAlD
Nortriptyline—CYP2E1—urine—bipolar disorder	0.00189	0.0244	CbGeAlD
Nortriptyline—HTR2A—telencephalic ventricle—bipolar disorder	0.0018	0.0232	CbGeAlD
Nortriptyline—HTR2A—urine—bipolar disorder	0.00165	0.0212	CbGeAlD
Nortriptyline—SLC6A4—blood plasma—bipolar disorder	0.00162	0.0209	CbGeAlD
Nortriptyline—CYP3A4—urine—bipolar disorder	0.00152	0.0196	CbGeAlD
Nortriptyline—CYP2D6—urine—bipolar disorder	0.0015	0.0193	CbGeAlD
Nortriptyline—HTR1A—blood plasma—bipolar disorder	0.00144	0.0186	CbGeAlD
Nortriptyline—CYP2C19—blood plasma—bipolar disorder	0.00135	0.0173	CbGeAlD
Nortriptyline—CYP1A2—blood plasma—bipolar disorder	0.0011	0.0142	CbGeAlD
Nortriptyline—CYP3A5—blood plasma—bipolar disorder	0.00106	0.0137	CbGeAlD
Nortriptyline—Olopatadine—S100B—bipolar disorder	0.00105	0.133	CrCbGaD
Nortriptyline—CYP2C9—blood plasma—bipolar disorder	0.00104	0.0134	CbGeAlD
Nortriptyline—CYP2E1—blood plasma—bipolar disorder	0.000989	0.0127	CbGeAlD
Nortriptyline—CHRM4—nervous system—bipolar disorder	0.000985	0.0127	CbGeAlD
Nortriptyline—PTGS1—blood plasma—bipolar disorder	0.000953	0.0123	CbGeAlD
Nortriptyline—HTR6—nervous system—bipolar disorder	0.000882	0.0114	CbGeAlD
Nortriptyline—HTR2A—blood plasma—bipolar disorder	0.00086	0.0111	CbGeAlD
Nortriptyline—CYP3A4—blood plasma—bipolar disorder	0.000796	0.0102	CbGeAlD
Nortriptyline—CYP2D6—blood plasma—bipolar disorder	0.000783	0.0101	CbGeAlD
Nortriptyline—CHRM5—nervous system—bipolar disorder	0.00077	0.00992	CbGeAlD
Nortriptyline—CHRM4—brain—bipolar disorder	0.000753	0.0097	CbGeAlD
Nortriptyline—ADRA1B—nervous system—bipolar disorder	0.000704	0.00906	CbGeAlD
Nortriptyline—ADRA1D—nervous system—bipolar disorder	0.000688	0.00887	CbGeAlD
Nortriptyline—HTR6—brain—bipolar disorder	0.000674	0.00868	CbGeAlD
Nortriptyline—CHRM5—brain—bipolar disorder	0.000589	0.00758	CbGeAlD
Nortriptyline—ORM1—nervous system—bipolar disorder	0.000567	0.0073	CbGeAlD
Nortriptyline—ADRA1B—brain—bipolar disorder	0.000538	0.00693	CbGeAlD
Nortriptyline—CHRM2—nervous system—bipolar disorder	0.000529	0.00681	CbGeAlD
Nortriptyline—ADRA1D—brain—bipolar disorder	0.000526	0.00678	CbGeAlD
Nortriptyline—CHRM3—thyroid gland—bipolar disorder	0.000512	0.00659	CbGeAlD
Nortriptyline—HTR2C—nervous system—bipolar disorder	0.00051	0.00656	CbGeAlD
Nortriptyline—SLC6A4—nervous system—bipolar disorder	0.000483	0.00622	CbGeAlD
Nortriptyline—CHRM1—nervous system—bipolar disorder	0.000481	0.0062	CbGeAlD
Nortriptyline—CHRM3—nervous system—bipolar disorder	0.000431	0.00555	CbGeAlD
Nortriptyline—HTR1A—nervous system—bipolar disorder	0.000429	0.00552	CbGeAlD
Nortriptyline—SLC6A2—nervous system—bipolar disorder	0.000425	0.00548	CbGeAlD
Nortriptyline—CHRM2—brain—bipolar disorder	0.000404	0.0052	CbGeAlD
Nortriptyline—HTR1A—cerebellum—bipolar disorder	0.000404	0.0052	CbGeAlD
Nortriptyline—ADRA1A—nervous system—bipolar disorder	0.000395	0.00509	CbGeAlD
Nortriptyline—HTR2C—brain—bipolar disorder	0.00039	0.00502	CbGeAlD
Nortriptyline—CYP1A2—thyroid gland—bipolar disorder	0.000389	0.00501	CbGeAlD
Nortriptyline—DRD2—nervous system—bipolar disorder	0.000388	0.00499	CbGeAlD
Nortriptyline—ALB—brain—bipolar disorder	0.00038	0.00489	CbGeAlD
Nortriptyline—Amitriptyline—NTRK2—bipolar disorder	0.000376	0.0476	CrCbGaD
Nortriptyline—ADRA1A—cerebellum—bipolar disorder	0.000372	0.00479	CbGeAlD
Nortriptyline—SLC6A4—brain—bipolar disorder	0.000369	0.00476	CbGeAlD
Nortriptyline—CHRM1—brain—bipolar disorder	0.000368	0.00474	CbGeAlD
Nortriptyline—DRD2—cerebellum—bipolar disorder	0.000365	0.0047	CbGeAlD
Nortriptyline—CYP2E1—thyroid gland—bipolar disorder	0.00035	0.0045	CbGeAlD
Nortriptyline—PTGS1—thyroid gland—bipolar disorder	0.000337	0.00434	CbGeAlD
Nortriptyline—CHRM3—brain—bipolar disorder	0.000329	0.00424	CbGeAlD
Nortriptyline—HTR1A—brain—bipolar disorder	0.000328	0.00422	CbGeAlD
Nortriptyline—SLC6A2—brain—bipolar disorder	0.000325	0.00419	CbGeAlD
Nortriptyline—HRH1—nervous system—bipolar disorder	0.000306	0.00394	CbGeAlD
Nortriptyline—ADRA1A—brain—bipolar disorder	0.000302	0.00389	CbGeAlD
Nortriptyline—DRD2—brain—bipolar disorder	0.000296	0.00381	CbGeAlD
Nortriptyline—CYP2E1—nervous system—bipolar disorder	0.000294	0.00379	CbGeAlD
Nortriptyline—PTGS1—nervous system—bipolar disorder	0.000283	0.00365	CbGeAlD
Nortriptyline—CYP2E1—cerebellum—bipolar disorder	0.000277	0.00356	CbGeAlD
Nortriptyline—HTR2A—nervous system—bipolar disorder	0.000256	0.00329	CbGeAlD
Nortriptyline—Protriptyline—SLC6A4—bipolar disorder	0.000244	0.0309	CrCbGaD
Nortriptyline—HTR2A—cerebellum—bipolar disorder	0.000241	0.0031	CbGeAlD
Nortriptyline—CYP3A4—nervous system—bipolar disorder	0.000237	0.00305	CbGeAlD
Nortriptyline—HRH1—brain—bipolar disorder	0.000234	0.00301	CbGeAlD
Nortriptyline—CYP2D6—nervous system—bipolar disorder	0.000233	0.003	CbGeAlD
Nortriptyline—Amitriptyline—NTRK1—bipolar disorder	0.000232	0.0294	CrCbGaD
Nortriptyline—CYP2E1—brain—bipolar disorder	0.000225	0.0029	CbGeAlD
Nortriptyline—CYP2D6—cerebellum—bipolar disorder	0.000219	0.00282	CbGeAlD
Nortriptyline—PTGS1—brain—bipolar disorder	0.000217	0.00279	CbGeAlD
Nortriptyline—Maprotiline—SLC6A3—bipolar disorder	0.000208	0.0263	CrCbGaD
Nortriptyline—HTR2A—brain—bipolar disorder	0.000195	0.00252	CbGeAlD
Nortriptyline—Maprotiline—HTR2C—bipolar disorder	0.000188	0.0238	CrCbGaD
Nortriptyline—CYP2D6—brain—bipolar disorder	0.000178	0.00229	CbGeAlD
Nortriptyline—Cyproheptadine—HTR2C—bipolar disorder	0.000167	0.0211	CrCbGaD
Nortriptyline—Cyproheptadine—HTR1A—bipolar disorder	0.000162	0.0205	CrCbGaD
Nortriptyline—Maprotiline—DRD2—bipolar disorder	0.000155	0.0196	CrCbGaD
Nortriptyline—Mianserin—DRD3—bipolar disorder	0.00015	0.019	CrCbGaD
Nortriptyline—Atomoxetine—SLC6A3—bipolar disorder	0.000143	0.0181	CrCbGaD
Nortriptyline—Cyclobenzaprine—HTR2A—bipolar disorder	0.00014	0.0177	CrCbGaD
Nortriptyline—Mianserin—SLC6A3—bipolar disorder	0.00014	0.0177	CrCbGaD
Nortriptyline—Epinastine—HTR2A—bipolar disorder	0.000139	0.0176	CrCbGaD
Nortriptyline—Cyproheptadine—DRD2—bipolar disorder	0.000137	0.0174	CrCbGaD
Nortriptyline—Chlorprothixene—DRD3—bipolar disorder	0.000137	0.0173	CrCbGaD
Nortriptyline—Chlorprothixene—DRD1—bipolar disorder	0.000134	0.017	CrCbGaD
Nortriptyline—Atomoxetine—HTR2C—bipolar disorder	0.000129	0.0163	CrCbGaD
Nortriptyline—Mianserin—HTR2C—bipolar disorder	0.000126	0.016	CrCbGaD
Nortriptyline—Mianserin—HTR1A—bipolar disorder	0.000123	0.0155	CrCbGaD
Nortriptyline—Maprotiline—HTR2A—bipolar disorder	0.00012	0.0151	CrCbGaD
Nortriptyline—Trimipramine—SLC6A3—bipolar disorder	0.000118	0.0149	CrCbGaD
Nortriptyline—Clomipramine—HTR2C—bipolar disorder	0.000116	0.0146	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2C—bipolar disorder	0.000115	0.0145	CrCbGaD
Nortriptyline—Atomoxetine—SLC6A4—bipolar disorder	0.000107	0.0135	CrCbGaD
Nortriptyline—Trimipramine—HTR2C—bipolar disorder	0.000106	0.0134	CrCbGaD
Nortriptyline—Cyproheptadine—HTR2A—bipolar disorder	0.000106	0.0134	CrCbGaD
Nortriptyline—Mianserin—SLC6A4—bipolar disorder	0.000105	0.0132	CrCbGaD
Nortriptyline—Mianserin—DRD2—bipolar disorder	0.000104	0.0132	CrCbGaD
Nortriptyline—Trimipramine—HTR1A—bipolar disorder	0.000103	0.013	CrCbGaD
Nortriptyline—Desipramine—SLC6A3—bipolar disorder	0.000103	0.013	CrCbGaD
Nortriptyline—Doxepin—HTR2C—bipolar disorder	0.000101	0.0128	CrCbGaD
Nortriptyline—Doxepin—HTR1A—bipolar disorder	9.83e-05	0.0124	CrCbGaD
Nortriptyline—Clomipramine—SLC6A4—bipolar disorder	9.57e-05	0.0121	CrCbGaD
Nortriptyline—Chlorprothixene—DRD2—bipolar disorder	9.48e-05	0.012	CrCbGaD
Nortriptyline—Amitriptyline—DRD3—bipolar disorder	9.33e-05	0.0118	CrCbGaD
Nortriptyline—Desipramine—HTR2C—bipolar disorder	9.29e-05	0.0118	CrCbGaD
Nortriptyline—Desipramine—HTR1A—bipolar disorder	9.02e-05	0.0114	CrCbGaD
Nortriptyline—Trimipramine—SLC6A4—bipolar disorder	8.81e-05	0.0111	CrCbGaD
Nortriptyline—Trimipramine—DRD2—bipolar disorder	8.76e-05	0.0111	CrCbGaD
Nortriptyline—Imipramine—SLC6A3—bipolar disorder	8.73e-05	0.011	CrCbGaD
Nortriptyline—Doxepin—SLC6A4—bipolar disorder	8.39e-05	0.0106	CrCbGaD
Nortriptyline—Doxepin—DRD2—bipolar disorder	8.35e-05	0.0106	CrCbGaD
Nortriptyline—Atomoxetine—HTR2A—bipolar disorder	8.23e-05	0.0104	CrCbGaD
Nortriptyline—Mianserin—HTR2A—bipolar disorder	8.04e-05	0.0102	CrCbGaD
Nortriptyline—Imipramine—HTR2C—bipolar disorder	7.88e-05	0.00997	CrCbGaD
Nortriptyline—Amitriptyline—HTR2C—bipolar disorder	7.83e-05	0.00991	CrCbGaD
Nortriptyline—Desipramine—SLC6A4—bipolar disorder	7.7e-05	0.00974	CrCbGaD
Nortriptyline—Desipramine—DRD2—bipolar disorder	7.66e-05	0.00969	CrCbGaD
Nortriptyline—Imipramine—HTR1A—bipolar disorder	7.65e-05	0.00968	CrCbGaD
Nortriptyline—Amitriptyline—HTR1A—bipolar disorder	7.6e-05	0.00962	CrCbGaD
Nortriptyline—Clomipramine—HTR2A—bipolar disorder	7.36e-05	0.0093	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2A—bipolar disorder	7.32e-05	0.00926	CrCbGaD
Nortriptyline—Trimipramine—HTR2A—bipolar disorder	6.77e-05	0.00856	CrCbGaD
Nortriptyline—Imipramine—SLC6A4—bipolar disorder	6.53e-05	0.00826	CrCbGaD
Nortriptyline—Imipramine—DRD2—bipolar disorder	6.5e-05	0.00821	CrCbGaD
Nortriptyline—Amitriptyline—SLC6A4—bipolar disorder	6.49e-05	0.00821	CrCbGaD
Nortriptyline—Amitriptyline—DRD2—bipolar disorder	6.46e-05	0.00816	CrCbGaD
Nortriptyline—Doxepin—HTR2A—bipolar disorder	6.45e-05	0.00816	CrCbGaD
Nortriptyline—Desipramine—HTR2A—bipolar disorder	5.92e-05	0.00748	CrCbGaD
Nortriptyline—Imipramine—HTR2A—bipolar disorder	5.02e-05	0.00635	CrCbGaD
Nortriptyline—Amitriptyline—HTR2A—bipolar disorder	4.99e-05	0.00631	CrCbGaD
Nortriptyline—HRH1—Signaling Pathways—DRD3—bipolar disorder	8.76e-06	5.85e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—DRD2—bipolar disorder	8.75e-06	5.84e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NTRK2—bipolar disorder	8.74e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	8.74e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CACNB2—bipolar disorder	8.74e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—TSHB—bipolar disorder	8.74e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—TPH2—bipolar disorder	8.74e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD3—bipolar disorder	8.73e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—GSK3A—bipolar disorder	8.72e-06	5.82e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NRG1—bipolar disorder	8.71e-06	5.81e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD3—bipolar disorder	8.71e-06	5.81e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—POMC—bipolar disorder	8.7e-06	5.81e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HTR2A—bipolar disorder	8.7e-06	5.8e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	8.7e-06	5.8e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3C2A—bipolar disorder	8.68e-06	5.79e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—GSK3A—bipolar disorder	8.67e-06	5.78e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—DRD4—bipolar disorder	8.66e-06	5.78e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	8.66e-06	5.78e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—POMC—bipolar disorder	8.66e-06	5.78e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	8.64e-06	5.76e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD3—bipolar disorder	8.62e-06	5.75e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—DPYD—bipolar disorder	8.6e-06	5.74e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	8.6e-06	5.74e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	8.58e-06	5.73e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	8.56e-06	5.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	8.56e-06	5.71e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD4—bipolar disorder	8.52e-06	5.69e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD4—bipolar disorder	8.51e-06	5.67e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD4—bipolar disorder	8.48e-06	5.66e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD4—bipolar disorder	8.45e-06	5.64e-05	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—POMC—bipolar disorder	8.41e-06	5.61e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD4—bipolar disorder	8.37e-06	5.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	8.35e-06	5.57e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	8.32e-06	5.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	8.29e-06	5.53e-05	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	8.28e-06	5.52e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	8.28e-06	5.52e-05	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—POMC—bipolar disorder	8.26e-06	5.51e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CLOCK—bipolar disorder	8.25e-06	5.5e-05	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	8.24e-06	5.49e-05	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	8.21e-06	5.48e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HTR2A—bipolar disorder	8.2e-06	5.47e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NRG1—bipolar disorder	8.19e-06	5.47e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CLOCK—bipolar disorder	8.18e-06	5.46e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ADCY2—bipolar disorder	8.15e-06	5.44e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—COMT—bipolar disorder	8.15e-06	5.44e-05	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	8.13e-06	5.42e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	8.13e-06	5.42e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	8.11e-06	5.41e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—S100B—bipolar disorder	8.09e-06	5.4e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—MAOA—bipolar disorder	8.09e-06	5.4e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—S100B—bipolar disorder	8.05e-06	5.37e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—TPH2—bipolar disorder	8.04e-06	5.36e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—TSHB—bipolar disorder	8.04e-06	5.36e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CACNB2—bipolar disorder	8.04e-06	5.36e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	8.02e-06	5.35e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ADCY2—bipolar disorder	8.02e-06	5.35e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ADCY2—bipolar disorder	8.01e-06	5.34e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ADCY2—bipolar disorder	8e-06	5.34e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	8e-06	5.33e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CACNA1C—bipolar disorder	8e-06	5.33e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	7.98e-06	5.32e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	7.98e-06	5.32e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CACNB2—bipolar disorder	7.97e-06	5.32e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—TPH2—bipolar disorder	7.97e-06	5.32e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—TSHB—bipolar disorder	7.97e-06	5.32e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NR1D1—bipolar disorder	7.96e-06	5.31e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	7.96e-06	5.31e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	7.95e-06	5.31e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD2—bipolar disorder	7.94e-06	5.3e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	7.93e-06	5.29e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	7.93e-06	5.29e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD2—bipolar disorder	7.92e-06	5.29e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—DPYD—bipolar disorder	7.91e-06	5.28e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD2—bipolar disorder	7.9e-06	5.27e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	7.88e-06	5.26e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD2—bipolar disorder	7.87e-06	5.25e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HTR2A—bipolar disorder	7.86e-06	5.24e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	7.86e-06	5.24e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	7.85e-06	5.24e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—DPYD—bipolar disorder	7.84e-06	5.23e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	7.83e-06	5.22e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD2—bipolar disorder	7.8e-06	5.2e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	7.79e-06	5.2e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—SNAP25—bipolar disorder	7.78e-06	5.19e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	7.78e-06	5.19e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—S100B—bipolar disorder	7.7e-06	5.14e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	7.69e-06	5.13e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—POMC—bipolar disorder	7.64e-06	5.1e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NCAN—bipolar disorder	7.62e-06	5.08e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—POMC—bipolar disorder	7.52e-06	5.02e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—POMC—bipolar disorder	7.5e-06	5.01e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—POMC—bipolar disorder	7.48e-06	4.99e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SLC5A3—bipolar disorder	7.46e-06	4.98e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—POMC—bipolar disorder	7.45e-06	4.97e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—MTHFR—bipolar disorder	7.43e-06	4.95e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HTR2A—bipolar disorder	7.39e-06	4.93e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—POMC—bipolar disorder	7.38e-06	4.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	7.36e-06	4.91e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CACNA1C—bipolar disorder	7.35e-06	4.91e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NTRK1—bipolar disorder	7.31e-06	4.87e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CACNA1C—bipolar disorder	7.29e-06	4.86e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	7.19e-06	4.8e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NTRK1—bipolar disorder	7.17e-06	4.79e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	7.17e-06	4.78e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	7.15e-06	4.77e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NRG1—bipolar disorder	7.14e-06	4.76e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	7.13e-06	4.76e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	7.1e-06	4.74e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NRG1—bipolar disorder	7.1e-06	4.74e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—S100B—bipolar disorder	7.1e-06	4.74e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	7.06e-06	4.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	7.04e-06	4.7e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	7.01e-06	4.68e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—GSK3B—bipolar disorder	7e-06	4.67e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CLOCK—bipolar disorder	6.99e-06	4.66e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—S100B—bipolar disorder	6.99e-06	4.66e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—SNAP25—bipolar disorder	6.99e-06	4.66e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—S100B—bipolar disorder	6.97e-06	4.65e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—S100B—bipolar disorder	6.95e-06	4.64e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—POMC—bipolar disorder	6.95e-06	4.63e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—S100B—bipolar disorder	6.93e-06	4.62e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—INS—bipolar disorder	6.91e-06	4.61e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—ADCY2—bipolar disorder	6.89e-06	4.6e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—COMT—bipolar disorder	6.86e-06	4.58e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—S100B—bipolar disorder	6.86e-06	4.58e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—COMT—bipolar disorder	6.85e-06	4.57e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—S100B—bipolar disorder	6.84e-06	4.57e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—MAOA—bipolar disorder	6.82e-06	4.55e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—TPH2—bipolar disorder	6.81e-06	4.54e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—TSHB—bipolar disorder	6.81e-06	4.54e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CACNB2—bipolar disorder	6.81e-06	4.54e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—MAOA—bipolar disorder	6.8e-06	4.54e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	6.8e-06	4.54e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—DPYD—bipolar disorder	6.7e-06	4.47e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—GSK3B—bipolar disorder	6.61e-06	4.41e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—MTHFR—bipolar disorder	6.59e-06	4.39e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—POMC—bipolar disorder	6.55e-06	4.37e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—INS—bipolar disorder	6.52e-06	4.35e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	6.44e-06	4.29e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—SNAP25—bipolar disorder	6.43e-06	4.29e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	6.4e-06	4.27e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—SNAP25—bipolar disorder	6.37e-06	4.25e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—GSK3B—bipolar disorder	6.33e-06	4.22e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—POMC—bipolar disorder	6.27e-06	4.19e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NRG1—bipolar disorder	6.27e-06	4.18e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—INS—bipolar disorder	6.24e-06	4.16e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CACNA1C—bipolar disorder	6.23e-06	4.16e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ADCY2—bipolar disorder	6.18e-06	4.13e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NRG1—bipolar disorder	6.17e-06	4.12e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NRG1—bipolar disorder	6.16e-06	4.11e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NRG1—bipolar disorder	6.14e-06	4.09e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	6.13e-06	4.09e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NRG1—bipolar disorder	6.12e-06	4.08e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	6.07e-06	4.05e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NRG1—bipolar disorder	6.06e-06	4.04e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	6.04e-06	4.03e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.99e-06	4e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—GSK3B—bipolar disorder	5.95e-06	3.97e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—POMC—bipolar disorder	5.94e-06	3.96e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—INS—bipolar disorder	5.91e-06	3.94e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—COMT—bipolar disorder	5.9e-06	3.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—POMC—bipolar disorder	5.9e-06	3.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—INS—bipolar disorder	5.87e-06	3.91e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MAOA—bipolar disorder	5.86e-06	3.91e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ADCY2—bipolar disorder	5.69e-06	3.8e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HTR2A—bipolar disorder	5.65e-06	3.77e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ADCY2—bipolar disorder	5.64e-06	3.76e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HTR2A—bipolar disorder	5.55e-06	3.7e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—MTHFR—bipolar disorder	5.55e-06	3.7e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—MTHFR—bipolar disorder	5.54e-06	3.69e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	5.53e-06	3.69e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	5.51e-06	3.68e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	5.46e-06	3.64e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	5.45e-06	3.63e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—SNAP25—bipolar disorder	5.45e-06	3.63e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CLOCK—bipolar disorder	5.39e-06	3.6e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—COMT—bipolar disorder	5.3e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—POMC—bipolar disorder	5.27e-06	3.51e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MAOA—bipolar disorder	5.26e-06	3.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TSHB—bipolar disorder	5.26e-06	3.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TPH2—bipolar disorder	5.26e-06	3.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CACNB2—bipolar disorder	5.26e-06	3.51e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—INS—bipolar disorder	5.24e-06	3.49e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	5.18e-06	3.46e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—DPYD—bipolar disorder	5.17e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	5.16e-06	3.44e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—POMC—bipolar disorder	5.14e-06	3.43e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—POMC—bipolar disorder	5.11e-06	3.41e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—INS—bipolar disorder	5.11e-06	3.41e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—INS—bipolar disorder	5.09e-06	3.39e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	4.94e-06	3.29e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—POMC—bipolar disorder	4.9e-06	3.27e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—COMT—bipolar disorder	4.87e-06	3.25e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—INS—bipolar disorder	4.87e-06	3.25e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MAOA—bipolar disorder	4.84e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—COMT—bipolar disorder	4.83e-06	3.22e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ADCY2—bipolar disorder	4.82e-06	3.22e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CACNA1C—bipolar disorder	4.81e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MAOA—bipolar disorder	4.8e-06	3.2e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MTHFR—bipolar disorder	4.77e-06	3.18e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	4.69e-06	3.13e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—GSK3B—bipolar disorder	4.55e-06	3.04e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—POMC—bipolar disorder	4.51e-06	3.01e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—INS—bipolar disorder	4.49e-06	2.99e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	4.48e-06	2.99e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—GSK3B—bipolar disorder	4.47e-06	2.98e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	4.45e-06	2.97e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—POMC—bipolar disorder	4.44e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	4.44e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—POMC—bipolar disorder	4.44e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—POMC—bipolar disorder	4.43e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—POMC—bipolar disorder	4.43e-06	2.95e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—POMC—bipolar disorder	4.42e-06	2.95e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—INS—bipolar disorder	4.42e-06	2.95e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—INS—bipolar disorder	4.41e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—INS—bipolar disorder	4.41e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—INS—bipolar disorder	4.4e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—POMC—bipolar disorder	4.4e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	4.4e-06	2.93e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—INS—bipolar disorder	4.39e-06	2.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	4.38e-06	2.93e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—INS—bipolar disorder	4.38e-06	2.92e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—POMC—bipolar disorder	4.36e-06	2.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—POMC—bipolar disorder	4.35e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—INS—bipolar disorder	4.34e-06	2.89e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—INS—bipolar disorder	4.32e-06	2.89e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MTHFR—bipolar disorder	4.28e-06	2.86e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SNAP25—bipolar disorder	4.2e-06	2.8e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—COMT—bipolar disorder	4.13e-06	2.75e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MAOA—bipolar disorder	4.1e-06	2.73e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MTHFR—bipolar disorder	3.94e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MTHFR—bipolar disorder	3.9e-06	2.6e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—POMC—bipolar disorder	3.81e-06	2.54e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—INS—bipolar disorder	3.79e-06	2.53e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ADCY2—bipolar disorder	3.72e-06	2.48e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—POMC—bipolar disorder	3.42e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—INS—bipolar disorder	3.4e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—bipolar disorder	3.34e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—COMT—bipolar disorder	3.18e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MAOA—bipolar disorder	3.16e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—POMC—bipolar disorder	3.15e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—INS—bipolar disorder	3.13e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—POMC—bipolar disorder	3.12e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—INS—bipolar disorder	3.1e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—POMC—bipolar disorder	2.67e-06	1.78e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—INS—bipolar disorder	2.65e-06	1.77e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—bipolar disorder	2.57e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—POMC—bipolar disorder	2.06e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—INS—bipolar disorder	2.05e-06	1.37e-05	CbGpPWpGaD
